openPR Logo
Press release

Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports.

09-23-2022 09:44 AM CET | Science & Education

Press release from: Valuates Reports

Neuromodulation market was valued at USD 2,480.2 million in 2020

Neuromodulation Market

Epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease are the most common neurological disorder, which affect the central and peripheral nervous system. These neurological disorders are caused by genetic disorders, congenital abnormalities or disorders, infections, lifestyle or environmental health problems, including malnutrition, and brain injury, spinal cord injury or nerve injury. Bacterial, viral, and fungal infections also responsible for neurological disorders.

Get a Free sample:

The increase in prevalence of neurological diseases globally drives the growth of the neuromodulation market. For instance, according to the Epilepsy Action organization, which is the British charity providing information for population with epilepsy, in February 2022, around 600,000 population are diagnosed with epilepsy, in UK, which is around one in every 100 population. In addition, increase in geriatric population propels the growth of neuromodulation market. The increase in R&D activities in the pharmaceutical sector and rise in number of clinical trials in the neuromodulation devices by manufacturers and researchers also contribute in the growth of market. Furthermore, surge in awareness for use of neuromodulation devices further boosts the market growth. The rise in number of hospitals and well-developed healthcare infrastructure further contributes in market growth.
In addition, increase in advancement in technology for neuromodulation devices and rise in product launch in the field of neuromodulation devices contribute in the growth of the neuromodulation market. However, the high cost of neuromodulation devices are expected to limit the growth of market.

Global Neuromodulation Market Segmentation

The neuromodulation market is segmented on the basis of technology, application, biomaterial, and region. By technology, the market is mainly categorized into internal neuromodulation and external neuromodulation. By application, it is categorized in chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications. On the basis of biomaterial, it is divided into, metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Abbott, Aleva, Neurotherapeutics SA., Boston Scientific Corporation, LivaNova, Medtronic, MicroTransponder, Neuronetics, NeuroPace Inc., NeuroSigma, and Nevro Corporation.

View full Report:


• The report provides an in-depth analysis of the global neuromodulation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global neuromodulation market growth.

Neuromodulation Market Segmentation

By Technology

• Internal Neuromodulation
• External Neuromodulation

By Application

• Chronic Pain
• Urinary And Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Other Applications

By Biomaterial

• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials

By Region

• North America
• Europe
• Asia-Pacific

Key Market Players

• LivaNova PLC
• Nevro Corporation
• Medtronic
• NeuroSigma
• Neuronetics
• Bioventus Inc.
• NeuroPace Inc
• MicroTransponder
• MicroTransponder
• Boston Scientific Corporation
• Abbot

Inquire For Regional Reports:

Similar Reports:
1. Deep Brain Stimulation System Market :

2. Overactive Bladder Treatment Device Market :

3. Medical RF Lesion Generator Market:

4. Radiofrequency Ablation Instrument Market:

5. Pain Management RF Lesion Generator Market :

U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at

4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports. here

News-ID: 2746866 • Views: 283

More Releases from Valuates Reports

The Biopesticides market was valued at USD 7,012.70 million in 2020, and is proj …
Biopesticide Biopesticide is a microbial toxin, which is biological poison generated from microorganisms such as bacteria or fungi. Pathogenesis by microbial entomopathogens begins with pathogen infiltration through the insect's stomach, followed by pathogen growth, which results in the insect's death. Get A Free Sample: The biopesticides market is primarily driven by the demand for organic goods and those generated via organic farming. Biopesticides, led by Bacillus thuringiensis (bt)-based products, have gained
Rapeseed oil market size was valued at USD 20,836.1 million in 2020 and is expec …
Rapeseed Oil Market Rapeseed, known as colza, is a member of the cruciferae family and is grown primarily for obtaining oil. The major sources of edible oils are rapeseed, copra, cottonseed, palm kernel, peanut, soybean, and sunflower seed. Oil is extracted either by mechanical extraction processes in oil mills or by chemical extraction using solvents. The oil content in rapeseeds is around 40%, and it is widely used in food
Cosmetic surgery market was valued at USD 67,289.1 million in 2021 and is projec …
Cosmetic surgery Market Cosmetic surgery is a type of plastic surgery that aims to improve a person's appearance. It is the unique discipline of medicine focused on enhancing appearance through surgical and medical techniques. Cosmetic surgery can be performed on any part of the face or body. It is a voluntary choice made by a patient to have cosmetic surgery. It includes body contouring, breast enhancement, facial contouring, facial rejuvenation,
In Vitro diagnostics (IVD) market was valued at $71,496.16 million in 2020 and i …
In vitro diagnostics (IVD) In vitro diagnostics (IVD) are defined as reagents, instruments, software and services that are used to examine specimens such as blood, urine, stool, tissues, and other human body fluids, to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point-ofcare centers. Some significant technologies incorporated in in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass

All 5 Releases

More Releases for Neuromodulation

Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Devices Market Analysis and Forecast Study for 2017-2027
Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation.Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum
Internal Neuromodulation Devices Market : Global Markets & Advanced Technologies
Internal neuromodulation devices directly act upon nerves. It is the technology known for alteration of nerve activity directly to a target area by sending electrical or pharmaceutical agents directly to a target area. The neuromodulation devices can treat nearly every disease considering every area of body. The diseases or symptoms from headache to spinal cord damage to tremor and many others. Neuromodulation technology is significantly improving in biotechnology with its
Global Neuromodulation Market Research Report 2016 - MRH
This report of MRH studies Neuromodulation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacture. Request Free Sample Report: Area Covering Medtronic, Inc. (U.S.) Boston Scientific Corporation (U.S.) St. Jude Medical, Inc. (U.S.) Synapse Biomedical, Inc. (U.S.) Nevro Corporation (U.S.) Neurosigma, Inc. (U.S.) Neuropace, Inc. (U.S.). Neuronetics, Inc. (U.S.) Cyberonics, Inc. (U.S.) BioControl Medical (Israel) Market Segment by Regions,
Europe Neuromodulation Devices And Implantable Infusion Pumps Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Europe Neuromodulation Devices And Implantable Infusion Pumps Market Report 2017" Description This report studies sales (consumption) of Neuromodulation Devices And Implantable Infusion Pumps in Europe market, especially in GermaAbout us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are